These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 28497249)

  • 1. The honeymoon period repeatedly appears in two cases of type 1 diabetes mellitus.
    Li S; Fang C; Huang Y; Guo H; Hu J
    Acta Diabetol; 2017 Sep; 54(9):877-880. PubMed ID: 28497249
    [No Abstract]   [Full Text] [Related]  

  • 2. [The classification and prognostic implication of islet β cell function before and in remission period in newly diagnosed diabetic patients with ketosis].
    Fan H; Zhang PR; Liu J; Xu Y
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):108-13. PubMed ID: 22490810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The honeymoon phase - what we know today about the factors that can modulate the remission period in type 1 diabetes.
    Sokołowska M; Chobot A; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2016; 22(2):66-70. PubMed ID: 28329775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The honeymoon phase: intersection of metabolism and immunology.
    Aly H; Gottlieb P
    Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):286-92. PubMed ID: 19506474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of autoimmunity risk loci on the honeymoon phase in type 1 diabetes.
    Moosavi M; Séguin J; Polychronakos C
    Pediatr Diabetes; 2017 Sep; 18(6):459-462. PubMed ID: 27503178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors.
    Abdul-Rasoul M; Habib H; Al-Khouly M
    Pediatr Diabetes; 2006 Apr; 7(2):101-7. PubMed ID: 16629716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The honeymoon period in non-insulin-dependent diabetes mellitus.
    Crump WJ
    J Fam Pract; 1987 Jul; 25(1):78-9, 82. PubMed ID: 3598482
    [No Abstract]   [Full Text] [Related]  

  • 8. Diet with a low n-6/n-3 essential fatty acid ratio when started immediately after the onset of overt diabetes prolongs survival of type 1 diabetes model NOD mice.
    Kagohashi Y; Otani H
    Congenit Anom (Kyoto); 2010 Dec; 50(4):226-31. PubMed ID: 20727002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus, advances and their implications for aerospace medicine.
    Cayce WR; Osswald SS; Thomas RA; Drew WE; Williams CS
    Aviat Space Environ Med; 1994 Dec; 65(12):1140-4. PubMed ID: 7872918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.
    Porter JR; Barrett TG
    Arch Dis Child; 2004 Dec; 89(12):1138-44. PubMed ID: 15557052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High glucose uptake by adipocytes in a type 1 diabetic patient with a partial 'honeymoon' period.
    Arrieta-Blanco FJ; Pulido N; Suarez A; Casanova B; Ramos F; Herrera-Pombo JL; Rovira A
    Diabet Med; 1998 Sep; 15(9):788-90. PubMed ID: 9737810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell mass and type 1 diabetes: going, going, gone?
    Akirav E; Kushner JA; Herold KC
    Diabetes; 2008 Nov; 57(11):2883-8. PubMed ID: 18971435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
    Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
    Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged honeymoon phase in an adolescent with diabetes and thyrotoxicosis provides support for the accelerator hypothesis.
    Abdullah N; Al-Khalidi O; Brown KJ; Reid J; Cheetham TD
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):417-9. PubMed ID: 18221436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
    Medicherla S; Protter AA; Ma JY; Mangadu R; Almirez R; Koppelman B; Kerr I; Navas TA; Movius F; Reddy M; Liu YW; Luedtke G; Perumattam J; Mavunkel B; Dugar S; Schreiner GF
    J Pharmacol Exp Ther; 2006 Jul; 318(1):99-107. PubMed ID: 16603672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of diabetes mellitus.
    Radha V; Vimaleswaran KS; Deepa R; Mohan V
    Indian J Med Res; 2003 Jun; 117():225-38. PubMed ID: 14748467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes-related epidemiological, clinical and laboratory findings. An evaluation with special regard to autoimmunity in children.
    Karaguzel G; Ozer S; Akcurin S; Turkkahraman D; Bircan I
    Saudi Med J; 2007 Apr; 28(4):584-9. PubMed ID: 17457482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young.
    Raile K; Klopocki E; Holder M; Wessel T; Galler A; Deiss D; Müller D; Riebel T; Horn D; Maringa M; Weber J; Ullmann R; Grüters A
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2658-64. PubMed ID: 19417042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
    Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
    Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic autoimmunity in infants and pre-schoolers with type 1 diabetes.
    Hathout EH; Sharkey J; Racine M; Thomas W; Nahab F; El-Shahawy M; Mace JW
    Pediatr Diabetes; 2000 Sep; 1(3):131-4. PubMed ID: 15016223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.